Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002928771 | SCV003275208 | uncertain significance | not provided | 2023-05-22 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 327 of the KIAA0556 protein (p.Arg327His). This variant is present in population databases (rs767946597, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with KIAA0556-related conditions. ClinVar contains an entry for this variant (Variation ID: 2064291). |
Ambry Genetics | RCV004068012 | SCV004067213 | uncertain significance | not specified | 2023-06-27 | criteria provided, single submitter | clinical testing | The c.980G>A (p.R327H) alteration is located in exon 9 (coding exon 9) of the KIAA0556 gene. This alteration results from a G to A substitution at nucleotide position 980, causing the arginine (R) at amino acid position 327 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004744494 | SCV005345575 | benign | KATNIP-related disorder | 2024-09-16 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |